[Pathophysiology of myelodysplastic syndromes].
Physiopathologie des syndromes myélodysplasiques.
Erythropoiesis
Mutation
Mutations
Myelodysplastic syndrome
Splicing
Syndromes myélodysplasiques
Traduction
Translation
Épissage
Érythropoïèse
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
09
01
2023
accepted:
15
02
2023
medline:
13
11
2023
pubmed:
10
7
2023
entrez:
9
7
2023
Statut:
ppublish
Résumé
During aging, the onset of mutations at low frequency in hematopoietic cells or clonal hematopoiesis of indeterminate significance favors the evolution towards hemopathies such as myelodysplastic syndromes or acute leukemias, but also cardiovascular diseases and other pathologies. Acute or chronic inflammation related to age influences the clonal evolution and the immune response. Conversely, mutated hematopoietic cells create an inflammatory bone marrow environment facilitating their expansion. Various pathophysiological mechanisms depending on the type of mutation produce the diversity of phenotypes. Identifying factors affecting clonal selection is mandatory to improve patient care.
Identifiants
pubmed: 37423830
pii: S0007-4551(23)00281-3
doi: 10.1016/j.bulcan.2023.02.026
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
1097-1105Informations de copyright
Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.